Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05956834 · ClinicalTrials.gov registry record

A Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration (FTLD) Syndromes

A clinical trial of Frontotemporal Dementia and Progressive Supranuclear Palsy, sponsored by Massachusetts General Hospital.

Active
Registry status
60
Enrollment target
2
Study locations

NCT05956834 is a study of Frontotemporal Dementia and Progressive Supranuclear Palsy that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 60 participants, below the 1,195-participant average among 22 other Frontotemporal Dementia trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05956834, a study of Frontotemporal Dementia and Progressive Supranuclear Palsy, is active but no longer recruiting, sponsored by Massachusetts General Hospital.

ACTIVE NOT RECRUITING
Registry status
60 participants
Enrollment target
2
Study locations

Study Summary

The primary objective of this study is to enroll an observational cohort of approximately 60 patients with PSP over the course of 24 months using a multicenter study design and to follow each of them for 12 months. The secondary objective of this study is to develop a robust solution for multi-modal remote monitoring of motor symptoms and function in PSP that can be applied to other Frontotemporal lobar degeneration (FTLD) syndromes.

Conditions Studied

Frontotemporal Dementia Progressive Supranuclear Palsy CBD Corticobasal Degeneration Frontotemporal Lobar Degeneration FTD PSP

Interventions

  • DEVICE PAMSys
  • DEVICE LEGSys

Study Locations (2)

Maryland

  • Johns Hopkins School of Medicine - Baltimore

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2023-07-28
Est. Completion 2027-12-30

Sponsor

Massachusetts General Hospital

2,032 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05956834

The ClinicalTrials.gov registry entry for NCT05956834 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,195-participant average among 22 other Frontotemporal Dementia trials with a reported enrollment target (95% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 7 conditions, with Frontotemporal Dementia appearing as the primary indexed condition, and to 2 interventions - of which PAMSys is the first listed.

NCT05956834 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Maryland, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05956834 about?

NCT05956834 is a clinical study titled "A Multi-Modal Remote Monitoring Platform for Frontotemporal Lobar Degeneration (FTLD) Syndromes". The primary objective of this study is to enroll an observational cohort of approximately 60 patients with PSP over the course of 24 months using a multicenter study design and to follow each of them for 12 months. The secondary objective of this study is to develop a robust solution for multi-moda...

What is the current status of trial NCT05956834?

This trial is currently active not recruiting. The enrollment target is 60 participants. The study started on 2023-07-28. Estimated completion is 2027-12-30.

What conditions does trial NCT05956834 study?

This clinical trial studies the following conditions: Frontotemporal Dementia, Progressive Supranuclear Palsy, CBD, Corticobasal Degeneration, Frontotemporal Lobar Degeneration.

What interventions are being tested in trial NCT05956834?

The interventions under investigation include: PAMSys (DEVICE), LEGSys (DEVICE).

Who is sponsoring clinical trial NCT05956834?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05956834 being conducted?

This trial has 2 study locations across Maryland, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Frontotemporal Dementia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Frontotemporal Dementia

All registered trials for this condition

Progressive Supranuclear Palsy

All registered trials for this condition

Maryland

All trials with a study site in Maryland

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.